Cheryl R. Blanchard
President, CEO, Director at Anika Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Anika Therapeutics Inc., 3 years.
Anika Therapeutics Inc.
Director · President, CEO, Director
Dare Bioscience Inc.
Director
Chief executive roles
Anika Therapeutics Inc.
· President, CEO, Director
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2025 | Anika Therapeutics Inc. | Option exercise | +25,132 | — | — |
| Mar 17, 2025 | Anika Therapeutics Inc. | Shares withheld for tax | −12,152 | $15.91 | $193,338 |
| Mar 11, 2025 | Anika Therapeutics Inc. | Option exercise | +30,060 | — | — |
| Mar 11, 2025 | Anika Therapeutics Inc. | Shares withheld for tax | −12,675 | $16.79 | $212,813 |
| Mar 10, 2025 | Anika Therapeutics Inc. | Option exercise | +20,002 | — | — |
| Mar 10, 2025 | Anika Therapeutics Inc. | Shares withheld for tax | −5,871 | $16.62 | $97,576 |
| Mar 11, 2024 | Anika Therapeutics Inc. | Option exercise | +14,420 | — | — |
| Mar 11, 2024 | Anika Therapeutics Inc. | Shares withheld for tax | −6,973 | $25.42 | $177,254 |
| Mar 11, 2024 | Anika Therapeutics Inc. | Option exercise | +20,001 | — | — |
| Mar 11, 2024 | Anika Therapeutics Inc. | Shares withheld for tax | −6,473 | $25.42 | $164,544 |
| Mar 11, 2024 | Anika Therapeutics Inc. | Option exercise | +30,059 | — | — |
| Mar 11, 2024 | Anika Therapeutics Inc. | Shares withheld for tax | −14,534 | $25.79 | $374,832 |
| Apr 26, 2023 | Anika Therapeutics Inc. | Option exercise | +24,575 | — | — |
| Apr 26, 2023 | Anika Therapeutics Inc. | Shares withheld for tax | −10,900 | $26.34 | $287,106 |
| Mar 10, 2023 | Anika Therapeutics Inc. | Option exercise | +30,060 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.